Dissemin is shutting down on January 1st, 2025

Published in

American Association for Cancer Research, Cancer Epidemiology, Biomarkers & Prevention, 9(28), p. 1489-1494, 2019

DOI: 10.1158/1055-9965.epi-19-0232

Links

Tools

Export citation

Search in Google Scholar

Physical Activity, Sitting Time, and Risk of Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Other Myeloid Malignancies

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Abstract Introduction: There is limited research on associations of moderate-to-vigorous physical activity (MVPA) and sitting with risk of myeloid neoplasms (MN) or MN subtypes. We examined these associations in the Cancer Prevention Study-II Nutrition Cohort. Methods: Among 109,030 cancer-free participants (mean age 69.2, SD 6.1 years) in 1999, 409 were identified as having been diagnosed with a MN [n = 155 acute myeloid leukemia (AML), n = 154 myelodysplastic syndromes (MDS), n = 100 other ML] through June 2013. Cox proportional hazards regression was used to calculate multivariable adjusted hazard ratios (HR) and 95% confidence intervals (CI) for associations of MVPA (MET-h/wk) and sitting (h/d) with risk of all MN, myeloid leukemia only, MDS, and AML. Results: Compared with insufficient MVPA [>0–<7.5 metabolic equivalent hours/week (MET)-h/wk], the HR (95% CI) for meeting physical activity guidelines (7.5–<15 MET-h/wk MVPA) and risk of MN was 0.74 (95% CI, 0.56–0.98) and for doubling guidelines (15–<22.5 MET-h/wk) was 0.75 (0.53–1.07); however, there was no statistically significant association for higher MVPA (22.5+ MET-h/wk, HR, 0.93; 95% CI, 0.73–1.20). Similarly, meeting/doubling guidelines was associated with lower risk of MDS (HR, 0.57; 95% CI, 0.35–0.92/HR, 0.51; 95% CI, 0.27–0.98), but there was no association for 22.5+ MET-h/wk (HR, 0.93; 95% CI, 0.63–1.37). MVPA was not associated with risk of myeloid leukemia or AML. Sitting time was not associated with risk of any outcome. Conclusions: These results suggest that there may be a nonlinear association between MVPA and risk of MDS and possibly other MN. Impact: Further studies are needed to better understand the dose–response relationships between MVPA and risk of MDS, a highly fatal and understudied cancer.